(Q40426850)

English

Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

title

Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

author name string

John T Lee

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Linda S Steelman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

James A McCubrey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

publication date

1 June 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

published in

International Journal of Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

page(s)

1637-1644

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Identifiers

PubMed publication ID

15870880

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15870880

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15870880%20AND%20SRC:MED&resulttype=core&format=json

(Q40426850)

Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)